Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has issued an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the application for the quotation of 85,714,264 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting stakeholders by increasing the accessibility of its shares.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on the development of neurological therapies. The company is engaged in creating innovative treatments for neurodegenerative conditions.
Average Trading Volume: 428,090
Technical Sentiment Signal: Buy
Current Market Cap: A$13.01M
For an in-depth examination of NSB stock, go to TipRanks’ Overview page.